11 - 14 out of 14Page size: 10
  1. 2020

  2. Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents

    Krasavin, M., Kalinin, S., Sharonova, T. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 1555-1561 7 p.

    Research output: Contribution to journal › Article › peer-review

  3. Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity

    Krasavin, M., Sharonova, T., Sharoyko, V., Zhukovsky, D., Kalinin, S., Žalubovskis, R., Tennikova, T. & Supuran, C. T., 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 665-671 7 p.

    Research output: Contribution to journal › Article › peer-review

  4. 2019

  5. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment

    Krasavin, M., Shetnev, A., Sharonova, T., Baykov, S., Kalinin, S., Nocentini, A., Sharoyko, V., Poli, G., Tuccinardi, T., Presnukhina, S., Tennikova, T. B. & Supuran, C. T., 15 Feb 2019, In: European Journal of Medicinal Chemistry. 164, p. 92-105

    Research output: Contribution to journal › Article › peer-review

  6. 2018

  7. An efficient synthesis and antimicrobial evaluation of 5-alkenyl- and 5-styryl-1,2,4-oxadiazoles

    Tarasenko, M., Sidneva, V., Belova, A., Romanycheva, A., Шаронова, Т. В., Байков, С. В., Shetnev, A., Kofanov, E. & Кузнецов, М. А., Dec 2018, In: Arkivoc. 2018, 7, p. 458-470 13 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next

ID: 32562152